Target intelligence / Profile preview

Cell regeneration in epidermal tissue

Molecular classification
Other (biological process involving multiple targets), Transcription factor (e.g., MSX2, LEF1, TCF7, HMGA1, TFAP2C), Kinase (e.g., CDK9), Growth factor receptor (e.g., FGFR, EGFR, c-Met), Cell adhesion molecule (e.g., Integrins)
01

Overview

"Cell regeneration in epidermal tissue" refers to the process by which the outermost skin layer replaces damaged or dead cells through the activation and differentiation of epidermal stem cells, particularly those in the basal layer and hair follicle niches[1][2][4][5][6]. This regeneration is tightly regulated by a balance between stem cell self-renewal and differentiation, coordinated by signaling pathways such as Wnt/β-catenin, transcription factors (MSX2, LEF1, TFAP2C), kinases like CDK9, and growth factor receptors including EGFR and FGFR. These pathways help restore skin integrity after injury and maintain the skin’s barrier function, but can also be implicated in diseases if their regulation is disrupted. Because "cell regeneration in epidermal tissue" describes a process and not a unique molecule, it cannot be mapped to a specific target for drug development[1][2][4][5][6].

Other names
Epidermal regenerationSkin regenerationEpidermal tissue regeneration
02

Mechanism of action

Promotion of keratinocyte proliferation and migration; Activation or inhibition of Wnt/β-catenin pathway; Modulation of growth factor signaling (EGF, FGF, HGF pathways); Regulation of stem cell fate (balance between self-renewal and differentiation, e.g., via CDK9)

03

Biological functions

Cell proliferationCell differentiationWound healingBarrier formationTissue repair
04

Disease associations

Wound healing and repairScarring and fibrosisSkin cancer (regulation of regeneration is linked to carcinogenesis)Chronic wounds (impaired regeneration)
05

Safety considerations

Risks of promoting tumorigenesis (malignant transformation) if cell proliferation is uncontrolled[5][6]Scarring and fibrosis due to dysregulated regenerationChronic wounds from failure to regenerate
06

Interacting drugs

Growth factors and analogs (e.g., EGF, FGF analogs)

2 more in the full profile.

07

Biomarkers

Expression of β-catenin (Wnt pathway activity)[2]Markers for epidermal stem cells (e.g., integrin expression, CD34, keratin 15)Expression of keratinocyte differentiation genes

Beyond the preview

Go deeper on Cell regeneration in epidermal tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell regeneration in epidermal tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call